PepGen Inc. (NasdaqGS: PEPG)
Health Care · Biotechnology · US
$3.23
+7.86% today · +130.0% 1Y
PepGen Inc. (NasdaqGS: PEPG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $207.09M and employs 57 people.
Over the last twelve months the share price has gained 130.0%, trading between 1.13 and 7.80.
Tweenvest scores PepGen Inc. across four factors: quality 26/100. Its strongest factor is quality.
PEPG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $207.09M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.19
- Dividend yield
- —
- Beta (5Y)
- 1.89
- 52-week high
- $7.80
- 52-week low
- $1.13
- Avg volume (3M)
- —
- Shares outstanding
- 69.26M
- Employees
- 57
- Next earnings
- —
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
- ISIN
- US7133171055
- Founded
- 2018
- Listed since
- May 6, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $262.85 | -1.11% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.11 | -0.48% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.03 | -0.50% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $549.73 | -0.56% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $818.74 | -1.78% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $148.45 | -6.54% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.